We are live on ! Find out more
NEXI

NexImmune, Inc. Common Stock
NEXI

Delisted

NEXI was delisted on the 11th of July, 2024.

Back to rankings

52 hedge funds and large institutions have $40.1M invested in NexImmune, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

13% more funds holding

Funds holding: 46 → 52 (+6)

15% less capital invested

Capital invested by funds: $47.1M → $40.1M (-$6.95M)

59% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 17

Holders
52
Holders Change
+6
Holders Change %
+13.04%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
7
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ECG
EPIQ Capital Group
California
+$560K
2
BBHC
Brown Brothers Harriman & Co
New York
+$361K
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$279K
4
CG
Caprock Group
Idaho
+$166K
5
BCM
Bridgeway Capital Management
Texas
+$147K

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$1.4M
2
TCM
TimesSquare Capital Management
New York
-$998K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$800K
4
JMPWA
JP Morgan Private Wealth Advisors
California
-$461K
5
Millennium Management
Millennium Management
New York
-$284K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACH
1
ArrowMark Colorado Holdings
Colorado
$5.58M -$1.4M -19,087 -26%
AG
2
Artal Group
Luxembourg
$5.05M – – –
SPC
3
Slate Path Capital
New York
$3.89M – – –
BlackRock
4
BlackRock
New York
$3.47M -$64.7K -881 -3%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$3.37M – – –
AO
6
Allen Operations
New York
$2.68M – – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$2.21M +$1.61K +22 +0.1%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.73M -$800K -10,889 -40%
BM
9
Bridger Management
New York
$1.68M – – –
BBA
10
Baker Bros. Advisors
New York
$1.24M – – –
JP Morgan Chase
11
JP Morgan Chase
New York
$1.07M -$26.9K -367 -3%
State Street
12
State Street
Massachusetts
$901K +$55K +749 +10%
ECG
13
EPIQ Capital Group
California
$802K +$560K +7,624 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$782K -$29.7K -405 -5%
Northern Trust
15
Northern Trust
Illinois
$580K -$6.02K -82 -1%
MCM
16
M28 Capital Management
Connecticut
$562K – – –
BBHC
17
Brown Brothers Harriman & Co
New York
$517K +$361K +4,915 New
KCM
18
Kingdon Capital Management
New York
$497K – – –
PNC Financial Services Group
19
PNC Financial Services Group
Pennsylvania
$471K +$279K +3,804 +567%
6CM
20
683 Capital Management
New York
$424K – – –
First Manhattan
21
First Manhattan
New York
$384K -$164K -2,237 -38%
Renaissance Technologies
22
Renaissance Technologies
New York
$310K +$66.8K +910 +45%
CG
23
Caprock Group
Idaho
$238K +$166K +2,263 New
Edgewood Management
24
Edgewood Management
Connecticut
$236K – – –
BCM
25
Bridgeway Capital Management
Texas
$211K +$147K +2,000 New
1
2 3

NEXI Hedge Fund Activity: Q1 2022 in Review

52 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q1 2022, worth a combined $40.1M — down 15% from $47.1M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NEXI positions and 6 closed out — a net gain of 6 holders — while 7 added to existing stakes and 17 trimmed.

The largest buyer was EPIQ Capital Group, opening a new position worth an estimated $560K. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $1.4M.

  • 52 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q1 2022, up from 46 in Q4 2021.
  • Funds reported $40.1M of NexImmune, Inc. Common Stock stock for Q1 2022, down 15% quarter-over-quarter.
  • 12 funds opened new NexImmune, Inc. Common Stock positions in Q1 2022 and 6 closed out, a net change of +6 holders.
  • The largest NexImmune, Inc. Common Stock buyer in Q1 2022 was EPIQ Capital Group, an estimated $560K added.
  • The largest NexImmune, Inc. Common Stock seller in Q1 2022 was ArrowMark Colorado Holdings, an estimated $1.4M sold.

Based on aggregated 13F filings for Q1 2022.